IL6 and keratoconus: Studies conducted after the turn of the new century have shown more consistent results with a statistically significant expression of common inflammatory biomarkers, such as interleukin-6 (IL-6) and inflammation-associated proteinases such as matrix metalloproteinases (MMPs) in KC patients compared to control group [15,67,68], challenging the pre-existing classifications.